(Q48729015)

15 February 2018

title

The overexpression of epithelial cell adhesion molecule (EpCAM) in glioma. (English)

1 reference

15 February 2018

1 reference

1 reference

Xin Chen

1

1 reference

15 February 2018

Wei-Yuan Ma

2

1 reference

15 February 2018

Shang-Chen Xu

3

1 reference

15 February 2018

Yu Liang

4

1 reference

15 February 2018

Yi-Bing Fu

5

1 reference

15 February 2018

Bo Pang

6

1 reference

15 February 2018

Tao Xin

7

1 reference

15 February 2018

Hai-Tao Fan

8

1 reference

15 February 2018

Rui Zhang

9

1 reference

15 February 2018

Jian-Gang Luo

10

1 reference

15 February 2018

Wen-Qing Kang

11

1 reference

15 February 2018

Min Wang

12

1 reference

15 February 2018

Qi Pang

13

1 reference

15 February 2018

publication date

7 June 2014

1 reference

15 February 2018

Journal of Neuro-Oncology

published in

1 reference

15 February 2018

volume

119

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

39-47

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-014-1459-5

exact match

0 references

cites work

Epidemiology of brain tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

The 2007 WHO classification of tumors of the central nervous system - what has changed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Prognostic markers in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

EpCAM: another surface-to-nucleus missile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

EpCAM proteolysis: new fragments with distinct functions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

EpCAM (CD326) finding its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

EpCAM in carcinogenesis: the good, the bad or the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Epithelial cell adhesion molecule expression (CD326) in cancer: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

EpCAM and its potential role in tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Nuclear signalling by tumour-associated antigen EpCAM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Frequent EpCam protein expression in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Expression of RECK in endothelial cells of glioma: comparison with CD34 and VEGF expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Morphometric study of microvessels in primary CNS tumors and its correlation with tumor types and grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

The Ki-67 protein: from the known and the unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1459-5

On the abundance of EpCAM on cancer stem cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24906438

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ep-CAM overexpression in breast cancer as a predictor of survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24906438

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-014-1459-5

1 reference

15 February 2018

1 reference

15 February 2018